Method: Derived from FDA-cleared laboratory results. This ratio/index is not an FDA-cleared test. It aids clinician-directed risk assessment and monitoring and is not a stand-alone diagnosis. Inputs: ferritin, albumin.

The Ferritin-to-Albumin Ratio (FAR) integrates inflammation (ferritin) and nutritional status (albumin).

Similar biomarker tests from Superpower

FAQs about Ferritin-to-Albumin Ratio Test

Ferritin-to-Albumin Ratio (FAR) is a calculated index, not a standalone lab molecule. It’s computed by dividing your ferritin level by your albumin level. Ferritin reflects iron storage but also rises with inflammation or infection. Albumin is a major blood protein made by the liver and often falls with inflammation, malnutrition, or liver dysfunction. FAR helps combine iron metabolism and nutritional/inflammatory status into one interpretable value.

Ferritin alone can be misleading because it increases during systemic inflammation even when iron stores aren’t truly high. Albumin tends to decrease in many of the same states (chronic disease, infection, liver stress, protein depletion). Combining them into FAR amplifies patterns of systemic stress, making it easier to spot inflammation paired with iron imbalance or reduced liver protein synthesis - situations that single tests may miss.

FAR can flag “hidden” inflammation plus iron disruption that may be missed by ferritin alone. It can clarify fatigue when ferritin looks normal but inflammation is distorting interpretation. FAR also helps separate true iron overload from inflammation-driven ferritin elevation, supports tracking chronic disease activity over time, and may reveal early metabolic stress linked to insulin resistance and liver dysfunction. It’s most useful alongside CRP and liver enzymes.

A high FAR typically suggests ferritin is elevated and/or albumin is reduced - often reflecting systemic inflammation, infection, chronic disease, malnutrition, or liver dysfunction. Higher values (often above 5–10 depending on population) can indicate inflammation is outpacing protein synthesis and resilience. This pattern appears in autoimmune disease, kidney disease, heart failure, chronic infections, some cancers, and critical illness, and is linked to worse outcomes in hospitalized patients.

Low FAR often reflects balanced physiology - healthy ferritin with stable albumin and minimal systemic inflammation. However, a low ratio can also occur when ferritin is very low while albumin remains normal, which can signal true iron deficiency. This is common in menstruating women, adolescents, or people with low dietary iron or absorption issues. Symptoms may include fatigue, pale skin, and reduced exercise tolerance.

Ferritin can appear “normal” while still being influenced by inflammation, which can mask iron-related issues or signal immune activation. FAR adds context by incorporating albumin, which may drop during inflammation, chronic illness, or liver stress. When FAR is elevated, it can suggest fatigue is tied to systemic inflammation and metabolic stress rather than simple low iron - helping guide next steps such as evaluating CRP, liver enzymes, and symptom patterns.

High ferritin can reflect true iron overload or an inflammatory response. FAR helps by pairing ferritin with albumin: inflammation often pushes ferritin up while suppressing albumin production. An elevated FAR can therefore support the interpretation that high ferritin is inflammation-driven rather than purely excess iron stores. Clinically, FAR is best interpreted with inflammation markers (like CRP), liver enzymes, and the broader clinical picture.

Elevated FAR has been studied in conditions where iron dysregulation and protein depletion occur together, including sepsis and critical illness, cancer, chronic infections, autoimmune disease, kidney disease, heart failure, liver dysfunction, and metabolic disease. Higher ratios correlate with complications and poorer outcomes in hospitalized patients and can reflect chronic immune activation and reduced nutritional or liver synthetic reserve. Symptoms may include fatigue, weight loss, fluid retention, and slow wound healing.

FAR is most informative when interpreted with other markers. CRP helps confirm whether inflammation is present and driving ferritin upward. Liver enzymes provide context on liver stress or dysfunction, which can reduce albumin production and affect ferritin handling. Looking at FAR alongside CRP, liver enzymes, and symptoms helps differentiate iron deficiency, inflammation-driven ferritin changes, malnutrition, and liver-related causes - especially when trending results over time.

FAR is context-dependent and not yet standardized for routine clinical practice. Results can be distorted by acute illness, chronic disease activity, recent transfusion, infection, inflammatory flares, and liver function changes that lower albumin. Because ferritin is an acute-phase reactant, inflammation can elevate it independent of iron stores. FAR is often most useful when trended over time and interpreted with CRP, liver enzymes, and clinical symptoms.